2690
E. Dur, M. Bulut / Polyhedron 29 (2010) 2689–2695
the coumarin moiety. The combined structure of the coumarin and
Pc may be a potential candidate molecule in the application of pho-
todynamic therapy [28]. In view of the biological importance of
both ethyl 7-hydroxycoumarin-3-carboxylate and Pcs, it is worth-
while to combine these two functional molecules into a single
compound via a synthetic methodology and to prepare and charac-
terize their soluble metallophthalocyanines, which may also exhi-
bit biological activities.
This study concerns the synthesis, characterization and struc-
tural investigation of b-tetra(ethyl 7-oxycoumarin-3-carboxyl-
ate)-substituted Zn(II), Co(II), Cu(II) and Ni(II) Pcs (3–6). In
addition, the carboxylate functional groups of coumarino-ZnPc
(3) were reacted with morpholine in boiling DMF, yielding 3-car-
boxymorpholinamide (3b). The same product was obtained via
an acyl chloride intermediate of 3. Also, the ethyl carboxylate sub-
stituents of 3 were hydrolyzed with aqueous hydrochloric acid to
prepare a hot water soluble coumarino-ZnPc carrying a carboxylic
acid group in position 3 of each coumarin (3a). Reaction of this
coumarino-ZnPc with aqueous sodium hydroxide/silver nitrate or
aqueous sodium hydroxide in DMF afforded the corresponding
water soluble 3-carboxylatosilver (3c) or 3-carboxylatosodium
(3d) salt, respectively. The ligand (1) and the complexes (3–6 and
3a–3d) were characterized using physico-chemical methods like
1H NMR spectroscopy, elemental analysis, mass, electronic and IR
spectral measurements.
2.1.2. General procedure for the synthesis of 2(3),9(10),16(17),23(24)-
tetrakis[ethyl 7-oxycoumarin-3-carboxylate]phthalocyaninato metal
derivatives (3–6)
A mixture of compound 1 (0.1 g, 0.27 mmol) and 0.025 mmol
metal salts [Zn(OAc)2Á2H2O 0.014 g, Co(OAc)2Á4H2O 0.016 g,
Cu(OAc)2 0.009 g, Ni(OAc)2Á4H2O 0.016 g] in 2-chloronaphthalene
(2 mL) was heated and stirred at 170 °C for 24 h under N2 in a
sealed glass tube. After cooling to room temperature, the resulting
green–blue mixture was precipitated by ethanol and filtered off.
The product was washed with water, hot ethanol, acetone and
diethyl ether, and then dried.
2.1.2.1. 2(3),9(10),16(17),23(24)-tetrakis[ethyl 7-oxycoumarin-3-car-
boxylate]phthalocyaninatozinc(II) (3). This is soluble in THF, DMF,
DMA and DMSO. Yield: 0.024 g (22%). M.p. > 300 °C 1H NMR
(DMSO): d, ppm 7.00–7.62 (12H, m, Pc-H), 6.86–7.72 (12H, m, phe-
nyl-H), 8.80 (4H, s, coum.-4H), 1.29–4.18 (20H, m, alkyl-H). FT-IR
(KBr)
1718 (–C@O), 1599–1466 (Ar, –C@C–), 1392–1211 (Ar–O–C),
1087, 1043, 941, 834, 745. UV–Vis kmax (nm) (log ) in DMF: 324
(4.78), 629 (4.38), 676 (4.97). MALDI-TOF ( -cyanohydroxycin-
namic acid,
-CHCA as matrix) m/z: 1507.67 [M+H]+. Anal. Calc.
m
max/(cmÀ1): 3061–3030 (Ar–H), 2921–2854 (aliphatic CH),
e
a
a
for C80H48N8O20Zn: C, 63.71; H, 3.18; N, 7.43. Found: C, 63.89; H,
3.36; N, 7.23%.
2.1.2.2. 2(3),9(10),16(17),23(24)-tetrakis[7-oxycoumarin-3-carbox-
ylic acid]phthalocyaninatozinc(II) (3a). A solution of 2(3),9(10),
16(17),23(24)-tetrakis[ethyl 7-oxycoumarin-3-carboxylate]phtha-
locyaninatozinc (II) (3) (0.030 g, 0.019 mmol) in DMF (4 mL) con-
taining water (1.42 mL) and concentrated hydrochloric acid (37%,
0.14 mL) was refluxed for 12 h. After cooling to room temperature,
the resulting mixture was precipitated by ice and collected by cen-
trifuge. Then, the product was washed with water to neutralize it,
and dried in a vacuum oven.
2. Experimental
2.1. Synthesis
Ethyl 7-hydroxycoumarin-3-carboxylate (2) was prepared by a
reported procedure [23]. The starting material, 4-nitrophthalonitri-
le, was synthesized by using the literature method [9]. The purities
of ethyl 7-hydroxycoumarin-3-carboxylate (2) and 4-nitro-1,2-
dicyanobenzene were tested in each step by TLC. Routine IR spectra
were recorded on a Shimadzu Fourier Transform FTIR-8300 infrared
spectrophotometer using KBr pellets. The electronic spectra were
monitored on a Shimadzu UV-2450 UV–Vis spectrophotometer.
1H NMR spectra were recorded on a Varian Unity Inova 500 MHz
NMR spectrophotometer using TMS as an internal reference at the
Gebze Institute of Technology. Elemental analysis was performed
by the Instrumental Analysis Laboratory of TUBITAK Ankara Test
and Analysis Laboratory. Mass spectra were performed on a Bruker
Daltonic Autoflex III MALDI-TOF spectrometer at Marmara
University.
This product is soluble in hot water, THF, DMF, DMA and DMSO.
Yield: 0.015 g (55%). M.p. > 300 °C. FT-IR (KBr) m
max/(cmÀ1): 3423–
3200 (carboxyl OH), 3074–3051 (Ar–H), 1712 (lactone, –C@O),
1600–1469 (Ar, –C@C–), 1395–1212 (Ar–O–C), 1120, 1091, 1045,
985, 836, 745. UV–Vis kmax (nm) (log e) in DMF: 331 (4.54), 615
(4.19), 673 (4.62). MALDI-TOF (a-CHCA as matrix) m/z: 1394
[M]+. Anal. Calc. for C72H32N8O20Zn: C, 61.95; H, 2.31; N, 8.04.
Found: C, 61.19; H, 2.23; N, 8.27%.
2.1.2.3. 2(3),9(10),16(17),23(24)-tetrakis[7-oxycoumarin-3-(morpho-
line-4-carbonyl)]phthalocyaninatozinc(II)
(3b). Compound 3a
(0.015 g, 0.01 mmol) was refluxed with thionyl chloride (2 mL)
for 3 h and then the mixture was distilled to remove residual thio-
nyl chloride. After cooling to room temperature, morpholin
(0.003 g, 0.004 mmol) was added and the mixture was refluxed
in dry DMF (2 mL) for 8 h. The resulting mixture was precipitated
by ice and the product was collected by centrifuge. Then, the prod-
uct was washed with water to neutralize and dried in a vacuum
oven.
2.1.1. Ethyl 7-(3,4-dicyanophenoxy)coumarin-3-carboxylate (1)
Ethyl 7-hydroxycoumarin-3-carboxylate (2) (1.00 g, 4.27 mmol)
and 4-nitro-1,2-dicyanobenzene (0.74 g, 4.27 mmol) were dis-
solved in dry DMF (100 mL), anhydrous K2CO3 (0.89 g, 6.41 mmol)
was added and the mixture was heated and stirred for 24 h under
nitrogen at 50–60 °C. The reaction mixture was treated with di-
luted HCl under ice cooling. The brown precipitate that formed
was filtered, washed with water to neutralize it, and dried. This so-
lid was soluble in THF (tetrahydrofurane), CHCl3 (chloroform),
DMF, DMA (dimethylacetamide) and DMSO (dimethylsulfoxide).
This product is soluble in THF, DMF, DMA and DMSO. Yield:
0.009 g (56%). M.p. > 300 °C. 1H NMR (DMSO-d6) d (ppm): 6.92–
7.92 (12H, m, Pc-H), 6.88–7.72 (12H, m, phenyl-H), 8.65 (4H, s,
coum-4H), 367–3.46 (32H, m, morpholine-H). FT-IR (KBr) mmax
/
Yield: 0.84 g (54%); m.p. 261–265 °C. FT-IR (KBr)
m
max/(cmÀ1):
(cmÀ1): 3091–3032 (Ar–H), 2960–2850 (aliphatic CH), 1711 (–
3053–2997 (Ar–CH), 2935–2911 (aliphatic CH), 2333 (C„N),
1737 (–C@O), 1593–1484 (Ar, –C@C–), 1243 (Ar–O–Ar), 1170,
1115, 1035, 843, 797, 772, 632, 522, 456. 1H NMR (DMSO-d6) d
(ppm): 8.82 (s, 1H), 8.22 (d, J = 8.5 Hz, 1H), 8.19 (d, J = 8.5 Hz,
1H), 8.00 (d, J = 2.5 Hz, 1H), 7.70 (dd, J = 9.0 Hz and 2.5 Hz, 1H),
7.64 (dd, J = 9.0 and 2.5 Hz, 1H), 7.29 (d, J = 1.5 Hz, 1H), 4.30 (q,
J = 7.0 Hz, 2H), 1.31 (t, J = 7 Hz, 3H). MALDI-TOF m/z: 396
C@O), 1604–1467 (Ar, –C@C–), 1363–1250 (Ar–O–C), 1113, 1021,
746, 636. UV–Vis kmax (nm) (log
e) in DMF: 334 (4.45), 638
(4.23), 670 (4.31). MALDI-TOF (a-CHCA as matrix) m/z: 1670
[M]+. Anal. Calc. for C88H60N12O20Zn: C, 63.26; H, 3.62; N, 10.06.
Found: C, 63.45; H, 3.32; N, 10.27%.
2.1.2.4. 2(3),9(10),16(17),23(24)-tetrakis[silver 7-oxycoumarin-3-car-
boxylate] phthalocyaninatozinc(II) (3c). A solution of compound 3a
[M+2H2O] +. UV–Vis kmax (nm) (log
e
) in DMF: 313 (4.47).